PMC:7195088 / 5620-6066
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 155 | 271-279 | Species | denotes | patients | Tax:9606 |
| 190 | 251-258 | Chemical | denotes | LPV/RTV | MESH:C558899 |
| 191 | 359-368 | Chemical | denotes | darunavir | MESH:D000069454 |
| 215 | 262-270 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T24 | 262-270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 230-235 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T15 | 116-132 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T16 | 230-235 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T17 | 333-352 | Chemical | denotes | protease inhibitors | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
| T19 | 342-352 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T20 | 359-368 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T39 | 97-108 | Sentence | denotes | Question 2. |
| T40 | 109-149 | Sentence | denotes | Should antiviral agents be administered? |
| T41 | 150-280 | Sentence | denotes | At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. |
| T42 | 281-425 | Sentence | denotes | This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. |